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Abstract
Background
Understanding how vascular and metabolic factors impact on cognitive function is essential
to develop efficient therapies to prevent and treat cognitive losses in older age. Cerebral
metabolic rate of oxygen (CMRO2), cerebral blood flow (CBF) and venous oxygenation (Yv)
comprise key physiologic processes that maintain optimum functioning of neural activity.
Changes to these parameters across the lifespan may precede neurodegeneration and con-
tribute to age-related cognitive decline. This study examined differences in blood flow and
metabolism between 31 healthy younger (<50 years) and 29 healthy older (>50 years)
adults; and investigated whether these parameters contribute to cognitive performance.
Method
Participants underwent a cognitive assessment and MRI scan. Grey matter CMRO2 was
calculated from measures of CBF (phase contrast MRI), arterial and venous oxygenation
(TRUST MRI) to assess group differences in physiological function and the contribution of
these parameters to cognition.
Results
Performance on memory (p<0.001) and attention tasks (p<0.001) and total CBF were
reduced (p<0.05), and Yv trended toward a decrease (p = .06) in the older group, while grey
matter CBF and CMRO2 did not differ between the age groups. Attention was negatively
associated with CBF when adjusted (p<0.05) in the older adults, but not in the younger
group. There was no such relationship with memory. Neither cognitive measure was associ-
ated with oxygen metabolism or venous oxygenation in either age group.
Conclusion
Findings indicated an age-related imbalance between oxygen delivery, consumption and
demand, evidenced by a decreased supply of oxygen with unchanged metabolism resulting
PLOS ONE | https://doi.org/10.1371/journal.pone.0197055 May 22, 2018 1 / 21
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Catchlove SJ, Macpherson H, Hughes
ME, Chen Y, Parrish TB, Pipingas A (2018) An
investigation of cerebral oxygen utilization, blood
flow and cognition in healthy aging. PLoS ONE 13
(5): e0197055. https://doi.org/10.1371/journal.
pone.0197055
Editor: Stephen D. Ginsberg, Nathan S Kline
Institute, UNITED STATES
Received: July 30, 2017
Accepted: April 25, 2018
Published: May 22, 2018
Copyright: © 2018 Catchlove et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data has been de-
identified and included in an online repository,
accessible from https://figshare.com/articles/_/
5552887.
Funding: Research was supported by a grant from
the Barbara Dicker Brain Sciences Foundation
awarded to MEH. ME Hughes is supported by the
Australian National Imaging Facility. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
in increased oxygen extraction. CBF predicted attention when the age-effect was controlled,
suggesting a task- specific CBF- cognition relationship.
Introduction
Older age is accompanied by deteriorating cognitive abilities that occurs even in the absence of
neurological or neurodegenerative disease [1]. Neuropsychological studies have reported a sig-
nificant decline in the speed of information processing [2], attention [3, 4], working memory
and executive functions [5, 6]. Vascular dysfunction and cardiovascular disease (CVD) also
become increasingly prevalent and severe with age, and have been linked to both dementia
and cognitive impairment [7–10]. Current evidence suggests that CVD and CVD risk factors
such as diabetes, smoking and hypertension can accelerate cognitive decline by causing hyp-
oxia and cerebral hypoperfusion, amongst other pathophysiological processes [11–15]. Like-
wise, age-related cognitive decline has been attributed to compromised oxygen and nutrient
delivery from the cerebral circulation [16, 17], which is highlighted by the observation that
inspiration of oxygen-rich gas can significantly improve cognitive performance [18, 19].
In humans, the brain consumes roughly one-fifth of oxygen intake, while only making up
about 2% of body weight. Cerebral metabolic rate of oxygen (CMRO2), cerebral blood flow
(CBF) and venous oxygenation (Yv) are measurable indices that reflect brain energy homeosta-
sis. These parameters represent oxygen demand, supply and the portion of oxygen that
remains after demand has been met, respectively. Studies of age-related changes in supply and
metabolism of oxygen have produced inconsistent results. CMRO2 reflects the amount of oxy-
gen used by the brain tissue over time. A number of studies have reported that CMRO2 is
diminished in older adults [16, 20–28], while other work suggests there is little or no change
over the lifespan [29–31]. More recent studies examining aging-related changes in CMRO2
reported that the rate actually increased, perhaps due to decreased tissue volume of the elderly
brain [32], indeed, remaining neurons would need to expend more energy to maintain the
same level of function due to a greater workload [33].
Other research suggests that CMRO2 alterations across the lifespan may differ between gen-
ders, with males showing an age-related increase while females showed no significant change
[32]. Similarly, there are conflicting reports of age-associated changes to the supply of blood to
the brain. CBF has been found to decrease with age [24, 25, 34–39], yet others report no differ-
ences between younger and older individuals [23, 30, 40–42]. Gender differences [43], brain
region [21], and tissue atrophy with age [44], can confound findings of aging effects on CBF.
One study reported that cerebral venous oxygenation declined by 1.4% per decade from young
adulthood [33], indicating that the oxygen supply/demand equilibrium undergoes a gradual
change across the lifespan. It has been demonstrated that age-related changes in CBF and oxy-
gen metabolism are related to performance in healthy adults in calibrated fMRI studies [28,
45]. The present work aims to build upon limited healthy aging studies by examining separate
cognitive abilities of memory and attention to investigate whether CBF and CMRO2 contrib-
ute to cognitive performance in a task-specific manner.
Research indicates that decreased perfusion of the brain may precede and contribute to the
onset of clinical dementia [46]. The direct impact of changes in oxygen delivery, consumption
and metabolism on performance of memory and attention tasks in cognitively healthy individ-
uals remains to be clarified [47, 48]. Therefore, it is important to establish the magnitude and
direction of alterations in vascular and metabolic factors that occur over the healthy lifespan,
CMRO2, CBF and cognition in healthy aging
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and the contribution of these parameters to cognition. The present study aimed to investigate
the relationships between CBF, CMRO2 and cognitive performance in a cognitively intact pop-
ulation. To this end, we used a combination of magnetic resonance imaging and tests of neuro-
psychological functions to examine differences in CMRO2, CBF and cognitive performance
between younger (<50 years) and older (>50 years) healthy adults. Based on previous studies
[24, 33, 48, 49], it was expected that age-related reductions in CMRO2, CBF, as well as cogni-
tive function would be evident. Moreover, we investigated whether CMRO2 and CBF were
related to cognitive performance on tests of memory and attention.
Results
Table 1 shows the characteristics of the sample. The two age groups did not differ significantly
on measures of blood pressure, arterial oxygen saturation or heart rate. One-way ANOVAs
revealed that the groups differed on BMI, tCBF, intracranial and grey matter volumes, and
response times on both of the cognitive composite measures, while the differences in venous
oxygenation approached significance (p = 0.06). Older adults had higher average BMI and
response times on the cognitive tasks (i.e. slower processing), yet lower average tCBF, intracra-
nial and grey matter volumes than younger adults.
Table 1. Means, standard deviations for characteristics of the entire sample, and each age group separately.
Whole sample (n = 60)
Age range 21–75 years (M 46.9 SD
17.5)
Younger (n = 31)Ages 21–44 years (M29.97
SD6.17)
Older (n = 29) Ages 55–75 years(M65.00
SD5.56)
Years of education 17.2 (3.7) 18.37 (3.22) 15.81 (3.77)
TICS-m 29.35 (2.40)
BMI 24.0 (4.0) 22.61 (3.21) 25.45 (4.34)
Heart rate 67.0 (9.9) 67.46 (9.63) 66.50 (10.26)
Systolic pressure, mmHg 127.1 (16.3) 124.11 (16.32) 129.90 (16.09)
Diastolic pressure, mmHg 75.8 (10.8) 73.56 (10.69) 77.93 (10.57)
SpO2, % 98.3 (0.8) 98.45 (0.64) 98.21 (.92)
tCBF, ml/min 786.7 (157.1) 827.33 (147.33) 743.18 (157.99)
gmCBF, ml/100g/min 50.6 (10.2) 51.17 (10.12) 50.02 (10.36)
wmCBF, ml/100g/min 20.25 (4.07) 20.47 (4.05) 20.01 (4.14)
gmCMRO2 μmol/100g/
min
148.5 (28.2) 145.98 (30.94) 151.29 (25.18)
Yv, % 62.7 (5.4)† 63.94 (5.72) 61.38 (4.77)
ICV, cm3 1184.4 (126.1) 1237.04 (127.34) 1128.09 (98.96)
Vgm, cm3 703.8 (84.7) 751.46 (73.36) 652.83 (64.40)
Vwm, cm3 480.9 (56.3) 485.58 (60.44) 475.83 (52.18)
Memory mean RT, msec 908.2 (113.2) 839.05 (87.08) 982.10 (88.92)
Attention mean RT, msec 529.7 (84.3) 472.78 (62.32) 586.51 (62.31)
Note: Values displayed are M (SD). BMI, body mass index; tCBF, total cerebral blood flow; gmCBF, grey matter cerebral blood flow; CMRO2, grey matter cerebral
metabolic rate of oxygen; Yv, venous oxygenation; ICV, intracranial volume; Vgm, volume of grey matter; Vwm, volume of white matter; TICS-m, modified Telephone
Interview for Cognitive Status. Asterisks indicate statistically significant differences between the groups as revealed by one-way ANOVAs.
†p = 0.06
p<0.05
p<0.01
p<0.001
https://doi.org/10.1371/journal.pone.0197055.t001
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Age and gender effects on physiological measures
Univariate General Linear Models (GLMs) were performed on the data to assess the influences
of age and gender on physiological parameters for each age group separately.
In the younger group the main effect of gender approached significance, while age had no
association with tCBF. In older adults, gender was again approaching significance, whilst the
main effect of age was marginally significant (p = .056). Parameter estimates for the older age
group revealed that for each additional year of life, tCBF decreased by approximately 9.70ml/
min. The model for the younger group had an R2 of .12, while the model for the older group
had an R2 of .29. Results are shown in Table 2.
The same analysis was performed for the grey matter corrected blood flow measure
(gmCBF). As revealed in Table 3, in both groups there was a significant main effect of gender,
whilst age did not contribute significantly. On average, females had higher average gmCBF
than males in both groups (younger females 12.4ml/100g/min higher; older females 11.1 ml/
100g/min higher) when the effect of age was controlled for. The younger group model had an
R2 of .39 and the older group model had an R2 of .42.
Univariate GLM showed that there was a significant main effect of gender on gmCMRO2 in
both age groups, but age did not have a significant effect. On average females had higher
gmCMRO2 than males in the same age group when the age effect was controlled (younger =
38.7μmol/100g/min higher; older = 24.1μmol/100g/min). R2 for the younger model was .41,
and the older model R2 was .22. Table 4 shows the results.
Univariate GLMS performed for venous oxygenation showed that in the younger adult
group there were no significant main effects of gender (p = .61) or age (p = .83) on Yv (Model
R2 = .01). The older group showed a significant main effect of age (F (1, 26) = 10.09, p = .004),
but not gender (p = .68) on Yv, R
2 = .31. In older adults, parameter estimates showed that for
each additional year of life Yv decreased by .46% when gender effects were controlled.
Relationships between physiological measures and cognitive performance
Several univariate GLMs were performed to assess the contribution of physiological processes
to memory and attention in each age group separately. Each model assessed the main effects of
age, gender and years of education, and the physiological parameter in question, on the cogni-
tive composite score for each age group. Ratios of tCBF: Yv and gmCBF: Yv were calculated to
assess the rate of change in these parameters relative to one another. The use of this measure
Table 2. Univariate GLM for each age group, showing the age and gender main effects on tCBF.
Age group F p Partial Eta Squared
Younger Age .07 .796 .002
Gender 3.74 .063 .118
Older Age 3.99 .056 .133
Gender 3.76 .063 .126
https://doi.org/10.1371/journal.pone.0197055.t002
Table 3. Univariate GLM for each age-group, showing age and gender main effects on gmCBF.
Age group F p Partial Eta Squared
Younger Age .09 .769 .003
Gender 16.76 .000 .374
Older Age 2.59 .120 .091
Gender 12.28 .002 .321
https://doi.org/10.1371/journal.pone.0197055.t003
CMRO2, CBF and cognition in healthy aging
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enabled investigation of how the balance of CBF and Yv changes with age. One-way ANOVA
indicated that there were no significant differences in the ratio of tCBF: Yv between groups
(F (1, 59) = 11.52, p = .097) or in the ratio of gmCBF: Yv between groups (F (1, 59) = .075, p =
.79) indicating that the two parameters decrease at roughly the same rate in each age group, i.e.
as tCBF/ gmCBF decreases, there is a concomitant decrease in Yv.
Memory, blood flow and ratios of blood flow to venous oxygenation. There were no
significant effects of tCBF, age group, gender or years of education on memory score for either
younger or older adults. S1 Table in the Supplementary Material shows the F, p and partial eta
squared values for separate univariate GLMs for tCBF. Likewise, there were no significant
effects of gmCBF, age, gender or years of education on memory score in either younger or
older adults. S2 Table in Supplementary Material shows the values of statistical tests for
gmCBF and memory. The ratios of tCBF and gmCBF to Yv were found to have no significant
impact on memory scores for either age group.
Attention and tCBF. There were no significant effects of tCBF, age, gender or education
on attention score in the younger group. In the older group however, tCBF had a highly signif-
icant main effect on attention, as did education. Parameter estimates for the older group
revealed that for each additional 10ml/min of blood flow, reaction time on the attention tasks
increased by approximately 2.2msecs on average when the demographic characteristics were
controlled. R2 for the younger group was .08, whilst the older group R2 was .46. Table 5 below
shows the results.
Attention and gmCBF. There were significant main effects of gmCBF and years of educa-
tion on attention score in the older group, yet none of the variables contributed to attention
score significantly in the younger group. Parameter estimates for the older group revealed that
for each additional 10ml/100g grey matter/min of blood flow, reaction time on the attention
tasks increased by approximately 34.8msecs on average when the demographic characteristics
were controlled. R2 values were .07 for the younger group, and .43 for the older group. Table 6
displays the results.
Attention and tCBF: Yv ratio. Univariate GLM revealed that in the older group the ratio
of tCBF: Yv significantly contributed to attention score, as did years of education, see Table 6
Table 4. Univariate GLM for age-groups separately, showing age and gender main effects on gmCMRO2 .
Age group F p Partial Eta Squared
Younger Age .26 .618 .009
Gender 18.27 .000 .395
Older Age .75 .393 .028
Gender 7.33 .012 .220
https://doi.org/10.1371/journal.pone.0197055.t004
Table 5. Univariate GLM showing age, gender, education and tCBF main effects on attention for younger and
older adults.
Age group F p Partial Eta Squared
Younger Age 1.35 .257 .055
Gender .28 .605 .012
Education (years) .05 .833 .002
tCBF .85 .365 .036
Older Age 3.37 .081 .138
Gender 1.22 .282 .055
Education (years) 7.87 .011 .273
tCBF 8.56 .008 .289
https://doi.org/10.1371/journal.pone.0197055.t005
CMRO2, CBF and cognition in healthy aging
PLOS ONE | https://doi.org/10.1371/journal.pone.0197055 May 22, 2018 5 / 21
for statistics. Parameter estimates for the older group revealed that for each additional unit of
tCBF: Yv, attention score increased by approximately 15msecs on average when age, gender
and education were controlled. Age and gender did not predict any significant amount of vari-
ance. None of the variables contributed to attention score significantly in the younger group.
R2 values were .06 for the younger group, and .45 for the older group. Table 7 displays the
results.
Attention and gmCBF: Yv ratio. Univariate GLM revealed that in the older group the
ratio of gmCBF: Yv significantly contributed to attention score, as did years of education. Age
and gender did not predict any significant amount of variance. Parameter estimates for the
older group revealed that for each additional unit of gmCBF: Yv, attention score increased by
approximately 217msecs on average when age, gender and education were controlled. None of
the variables contributed to attention score significantly in the younger group. R2 values were
.05 for the younger group, and .40 for the older group. Table 8 displays the results.
Cognition, gmCMRO2 and Yv. Neither memory nor attention scores were significantly
related to gmCMRO2, age, gender or education in either the younger or the older group. It was
also found that there were no significant effects of Yv, age, gender or years of education on
either memory or attention score.
Summary
This study revealed the main findings that cognitive performance was significantly reduced in
older compared to younger adults; Older adults had significantly lower tCBF and grey matter
volume compared to younger adults, yet there were no differences between the groups on mea-
sures of gmCBF and gmCMRO2, whilst the difference in Yv was approaching significance; In
Table 6. Univariate GLM showing age, gender, education and gmCBF main effects on attention for younger and
older adults.
Age group F p Partial Eta Squared
Younger Age 1.20 .285 .049
Gender .36 .554 .015
Education (years) .04 .852 .002
gmCBF .51 .482 .022
Older Age 2.36 .139 .101
Gender 2.09 .163 .090
Education (years) 8.33 .009 .284
gmCBF 6.97 .015 .249
https://doi.org/10.1371/journal.pone.0197055.t006
Table 7. Univariate GLM showing age, gender, education and tCBF: Yv main effects on attention for younger and
older adults.
Age group F p Partial Eta Squared
Younger Age 1.14 .298 .047
Gender .21 .653 .009
Education (years) .01 .911 .001
tCBF: Yv .37 .551 .016
Older Age 1.48 .237 .066
Gender 1.04 .321 .047
Education (years) 8.10 .010 .278
tCBF: Yv 7.76 .011 .270
https://doi.org/10.1371/journal.pone.0197055.t007
CMRO2, CBF and cognition in healthy aging
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the older group, tCBF was marginally associated with age, and this association was attenuated
when corrected for grey matter volume; In the older group tCBF, gmCBF, tCBF: Yv ratio and
gmCBF: Yv ratio were associated with reaction times on attention tasks when age, gender and
education effects were controlled, yet no such associations were observed in the younger
group; In the older group, tCBF and the ratio of tCBF: Yv contributed greater amounts of vari-
ance to attention score than gmCBF in adjusted models; There were no significant contribu-
tions to memory tasks in either group, with any parameter.
Discussion
The present study investigated the relationships between brain oxygen metabolism, blood sup-
ply and cognitive function between healthy younger and older adults. It was hypothesized that
age-related declines in CBF, CMRO2 and cognition would be evident. Total blood flow in the
brain decreased with age; however when this was corrected for grey matter volume, grey mat-
ter blood flow did not differ between young and older adults. The rate of cerebral oxygen utili-
zation did not differ between groups, and the amount of oxygen extracted from the blood
showed a trend toward being increased in the older group compared to younger. Taken
together, these results suggest that there is some imbalance between the supply, consumption
and demand for oxygen in the brain with older age, a pattern demonstrated in previous
research [50]. A further aim of this study was to investigate the association of both CBF and
grey matter oxygen utilization with performance on specific cognitive domains of attention
and memory in healthy younger and older adults.
Advanced age in this sample was characterized by poorer performance on both the atten-
tion and memory measures of cognition and a reduced supply of blood to the neural tissue, yet
when corrected for grey matter volume this reduction in CBF was no longer apparent. This
was coupled with a trend toward increased oxygen extraction in the older group. In the older
group total CBF, grey matter CBF and the ratios of both total and grey matter CBF to venous
oxygenation contributed to attention score. Higher blood flow and ratios were associated with
slower reaction times. Memory function was not associated with any physiological variable in
the either group, and no relationships between physiological measures and cognitive perfor-
mance were observed in the younger group.
Age differences
Whole brain CBF was reduced in the older group, yet grey matter CBF was comparable
between groups. As hypothesized, total CBF was reduced in older adults compared to youn-
ger. These findings are supported by numerous reports of MRI-based [33–35, 44, 49, 51, 52]
Table 8. Univariate GLM showing age, gender, education and gmCBF: Yv main effects on attention for younger
and older adults.
Age group F p Partial Eta Squared
Younger Age .99 .329 .003
Gender .07 .795 .041
Education (years) .00 .965 .000
gmCBF: Yv .05 .834 .002
Older Age 1.70 .428 .030
Gender .65 .206 .075
Education (years) 8.42 .009 .286
gmCBF: Yv 5.72 .026 .214
https://doi.org/10.1371/journal.pone.0197055.t008
CMRO2, CBF and cognition in healthy aging
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and specifically phase contrast MRI research [48, 53]. However, when total flow was normal-
ized to the volume of grey matter, blood flow did not differ between groups. It is understood
that cerebral grey matter undergoes significant atrophy with age [54], a finding corroborated
in the present data. To account for this atrophy, we corrected for tissue volume in our estima-
tion of gmCBF. Once this volume reduction was accounted for, blood flow in the remaining
grey matter was found to be unchanged over the lifespan. This result, despite being in line with
some previous findings (e.g.[21, 50]), was unexpected, as grey matter CBF is generally under-
stood to decline with age, though CBF reduction across the brain is heterogeneous across
brain regions [35]. Thus, the current data may have failed to observe this decline by assessing
gmCBF as a derivative of grey matter volume, rather than regionally. According to the data
presented here, we can infer that while the total flow entering the brain may decrease with age,
blood supply to grey matter specifically does not change per se. This finding, coupled with age-
related decline in grey matter volume, suggests that the observed decrease in total flow may be
due to an overall reduction in volume with aging.
It was observed that there were differing patterns of age-related changes between the
groups. In the younger adults, there were no observed alterations of any vascular measure with
age, yet the older group showed significant age-related decreases in both blood flow and
venous oxygenation, whilst gmCMRO2 remained the same. This pattern of hemodynamic
changes suggests that in older age, neural tissue extracts greater amounts of oxygen from the
blood when the supply is reduced, in order to maintain the same level of oxygen consumption.
CMRO2 did not differ between age groups. Cerebral metabolic rate of oxygen use did
not differ between age groups. Previous PET studies of brain aging and CMRO2 have been
inconsistent. Most often oxygen utilization is observed to decrease with age [16, 20–28], yet
some studies have found an increase in oxygen demand with age [32, 33], and, in-keeping with
the current findings, other researchers have reported no change in CMRO2 over the lifespan
[21, 29, 30, 40, 55, 56].
The majority of this previous research utilized PET technology, making correction for
brain parenchyma volume reduction difficult and possibly resulting in underestimation of
CMRO2. Developments in MRI capabilities allow for greater sensitivity in detecting partial vol-
umes and accounting for brain atrophy, thus providing more robust estimation of oxygen use
[57]. The method employed in this study calculated the rate of oxygen use relative to the size of
the grey matter on an individual basis to overcome this potential limitation.
Lu et al. [33] reported that CMRO2 increased across the lifespan; however potential age-
related changes in hemoglobin concentration were not accounted for. The ability for blood to
carry oxygen, and thus the hemoglobin content, can decrease by a rate of 0.0079mmol/L per
year [21]. Researchers [32] re-analysed the data from Lu et al. [33] to include the potential age-
effect on hematocrit to demonstrate that the CMRO2 dependence on age was no longer signifi-
cant. Therefore, the present study adjusted for the effect of age on hemoglobin content, repli-
cating this result, which suggests that some previous findings may have overestimated the
change in CMRO2 that is truly attributable to aging rather than that which is dependent on
age-associated hemoglobin decrease.
Hemodynamic differences between groups. Consistent with others [33, 50, 58], oxygen-
ation of the venous blood declined with age in older adults (i.e. an increase in the oxygen
extraction fraction (OEF)), and this was coupled with a decrease in cerebral blood flow, while
CMRO2 remained constant. Overall decrease in blood supply without a proportionate fall in
metabolism would likely have this result [50]. The ratio of tCBF: Yv was trending towards a
decline in the older group as compared to the younger adults, suggesting that the equilibrium
between oxygen demand and whole brain blood supply is gradually altered across the lifespan.
This is possibly due to diminished efficiency of the neural tissue with aging; the brain tissue
CMRO2, CBF and cognition in healthy aging
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requires more oxygen from the blood supply to maintain the availability of oxygen in the brain
parenchyma, and thus, energy homeostasis. Previous research by Dastur et al. [50] using the
nitrous oxide method [59] showed a similar pattern of results wherein CBF and CMRO2
remained the same with age, matched with a trend toward decreased venous oxygenation. The
authors concluded that oxygen extraction from the arterial blood is increased over the lifespan
in order to maintain optimum CMRO2 levels due to relative circulatory insufficiency. Note
however, that no correction for brain volume was performed in this previous work, limiting the
comparability of results with the present findings, in which total CBF was reduced in the older
group compared to the younger, but CBF specific to grey matter tissue did not differ between
groups. Moreover, the ratio of grey matter blood flow to venous oxygenation was not statisti-
cally different between the two age groups; these two parameters thus vary at the same rate with
age. This highly non-significant result would indicate that the loss of gmCBF is in line with oxy-
gen extraction in both younger and older adulthood. This suggests that in normal, healthy aging
the cerebrovasculature is functioning beyond what is required to compensate for decreases in
flow and oxygen extraction, particularly when adjusted for the grey matter atrophy.
Regardless, if the ability of the circulatory system to adjust to local changes in supply and
requirement for oxygen is compromised by age-related pathologies such as hardening of ves-
sels or accumulation of arteriosclerotic plaques, then increased extraction of oxygen from the
circulating blood is the last remaining mechanism that can accommodate further demand,
even when blood flow is maintained.
Summary of age group differences. The current data showed a decrease in supply of
blood across the whole brain, yet flow and oxygen metabolism in the grey matter alone were
maintained. This was coupled with a trend toward an increase in oxygen extraction between
the age groups. This gradual shift in maintenance of energy homeostasis was accompanied by
declining grey matter volume. The measured decrease in total CBF appears to be primarily due
to atrophy of cortical tissue, rather than a true decline in flow. Overall, the data shows that
aged brains have less volume, yet receive the same amount of blood flow per 100g of tissue as
younger. This, matched with the observed trend towards an increase in oxygen extraction
from the blood, suggests that the aged brain requires greater amount of oxygen per unit of tis-
sue in order to maintain optimum metabolism.
Association between vascular factors and cognitive performance
The present study expanded on previous research by assessing the contributions of vascular
and metabolic factors to attention and memory in physically and cognitively healthy adults.
Consistent with previous research, attention and memory performance were lower in older
adults compared to younger [3, 5]. Statistical analyses showed differences in the contributions
of vascular factors to attention performance between the younger and older groups. While in
the older group there were significant associations of CBF and the ratio of CBF to venous oxy-
genation (a measure of the coupling of flow and consumption) to the attention composite
measure, these relationships were not observed in the younger adults. Memory was not associ-
ated with any physiological parameter in either group. This is in support of findings using
phase contrast MRI to show a task-specific CBF- cognition relationship, wherein CBF pre-
dicted attention and information processing speed [48, 52], but not memory measures [60].
In the older group, when adjusted for participant characteristics, attention task perfor-
mance was inversely related to blood flow, such that faster responses were associated with
lower blood flow. While these findings are consistent with previous research in healthy partici-
pants [e.g. 48, 52], this is opposite to the expected outcome, given that both CBF and cognitive
performance decrease with age.
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This finding is in line with those of previous healthy aging studies. For example, it was
found that blood flow in the carotid and basilar arteries in healthy older adults was negatively
correlated to cognitive processing speed [48]. Bertsch et al. [52] reported a similar inverse rela-
tionship between resting grey matter blood flow and selective attention and tonic alertness in
healthy individuals. The authors related their findings to the hypothesis of neural efficiency
[61]. This theory posits that general intelligence is not a reflection of how hard a brain works,
but due more to proficiency of neural circuits, as less ‘fuel’ i.e. oxygen and nutrients from the
circulation, is required when the brain is working more efficiently. Faster reaction time on the
attention tasks is assumed to represent more efficient processing. Attention and intelligence
measures have been shown to be highly associated [61, 62], lending support to the notion that
better performance on attention tasks could be linked to lower global blood flow.
Another study reporting significant correlations between cognition and resting CBF found
that once brain size was taken into account these associations disappeared [63]. In the present
study, global CBF predicted attention score, yet this association was attenuated when volume
of grey matter was accounted for, suggesting that some of blood flow effects are partially due
to brain atrophy [47]. Likewise, in the present research the ratio of total CBF: venous oxygen-
ation was found to predict attention score (a higher ratio was associated with slower responses
on attention tasks) when age, gender and education were controlled, however this relationship
was statistically weaker when corrected for grey matter volume. While this is difficult to inter-
pret, a possible explanation is that oxygen extraction may be driving this association; a lower
venous oxygen percentage (i.e. higher oxygen extraction) for the amount of blood flow could
signify that the brain tissue is more at risk, and this would present as a smaller ratio. The atten-
uation of the relationship between CBF: Yv ratio and attention score once brain tissue volume
is accounted for suggests that at least some portion of this flow/consumption coupling impact
is due to grey matter volume differences.
CMRO2 and Yv did not predict cognition. Contrary to expectations, grey matter
CMRO2 did not contribute to either memory or attention score, which could be the result of
the compensation between CBF and Yv. These findings have been corroborated in previous lit-
erature in studies of healthy aging [40, 63–65]. One study [64] found no association between
cerebral metabolism of glucose and visual memory performance in healthy adults. Researchers
concluded that resting brain metabolism is not linked with mental ability in the absence of dis-
ease. This notion is corroborated by Dastur et al. [50], who found a connection between men-
tal abilities and CMRO2 in normal older men with asymptomatic, sub-clinical vascular
disease, but not in men who were optimally healthy. The present study employed a rigorous
health screening questionnaire to exclude those presently or previously suffering disease or
poor health, lending support to these hypotheses. Similarly, oxygenation of the venous blood
was not associated with either cognitive measure. Previous research has linked lower oxygen
content in the jugular vein to post-operative cognitive dysfunction in patients [66], however
this is the first study to examine the association of venous oxygenation and cognitive perfor-
mance in a healthy population of younger and older adults.
Summary of vascular and metabolic contributions to cognitive performance. Taken
together, these results suggest that declining blood supply and grey matter volume results in
increased extraction of oxygen from the blood in order to maintain normal oxygen consump-
tion, a process that likely protects against neural impairment. Cognitive performance slows
even in healthy aging, and there are differences in the contribution of vascular factors to cogni-
tion from younger to older adulthood. Physiological factors were not found to contribute to
cognitive performance in the younger group. In older adults however, oxygen supply has an
inverse effect on attention when demographic characteristics are accounted for, such that
lower flow is associated with faster cognitive speed, perhaps indicating better neural efficiency.
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Furthermore, the ratio of blood flow to oxygen extraction also contributes to attention score.
Interestingly, these relationships are attenuated when grey matter atrophy is corrected for,
indicating that for these older, cognitively intact individuals, brain volume has some impact
on cognitive performance.
Limitations
The findings of the current study should be interpreted in light of some limitations. Partici-
pants were both healthier and more educated than what may be expected in the general popu-
lation of adults, and were selected for the purposes of reducing any unwanted confounding
variables in terms of biological aging. Care was taken to exclude individuals with cardiovascu-
lar risk factors that may confuse findings resulting from normal healthy aging.
Much of the previous research on CBF with aging has employed analysis based on brain
region, due to the acknowledged heterogeneity of blood flow across different brain areas [21].
Previous studies indicate that there is a greater decrease in CMRO2 in the grey compared to
white matter across the lifespan [67], and others [68] reported that CBF and CMRO2 reduc-
tions occur primarily in the parietal and temporal cortices, with other areas remaining unaf-
fected. The method employed in the present study is considered to be valid and reliable for
whole-brain estimation of CBF [63], and CMRO2 [32], yet does not allow for regional analysis
to be performed. Measurement of grey matter CMRO2 without analyzing by specific region
could underestimate the alteration in grey matter oxygen use whilst overestimating the oxygen
use in the white matter, thus cancelling out any age effect in some regions versus others. The
current study corrected for this by using the VBM toolbox in SPM12 (SPM12, University Col-
lege of London, UK) which uses an iterative method to optimally segment different tissue
types of the brain to calculate CMRO2 in the grey matter only. However, this approach doesn’t
allow for the distinction between grey and white matter contributions to the aging effect in
vascular and metabolic function. If there is a differential rate of change in tissue volume with
age, and this leads to changes in the ratio of grey to white matter across the lifespan, then
CMRO2 could appear to be modified without any true change in either grey or white matter
rate of oxygen use, yet even after accounting for this gmCMRO2 was not found to change
across the lifespan, a finding corroborated in the literature [24]. The data showed that both
grey and white matter was reduced in the older group compared to the younger adults, yet
only the grey matter difference was significant. It has been suggested that alterations of tissue
microstructure are the more commonly detected age-related change in white matter over vol-
ume reduction, and these structural changes are not easily observed using conventional
T1-weighted imaging [69].
Additionally, the CMRO2 values obtained in this study show some discrepancy when com-
pared to literature values (e.g. 146 μmolO2/100g/min on average in the younger group in the
current work, versus 171μmolO2/100g/min for an average 20 year old male reported in Aanerud
et al. [21], versus ~135μmolO2/100g/min for healthy controls reported in Thomas et al [70]).
Design differences between these studies (e.g. samples, measurement tools, variation in haema-
tocrit values) would limit the extent to which the specific values of CMRO2 can be compared.
CBF change over the lifespan is heterogeneous across different brain regions, and distinct
areas of the brain may be more responsible for cognitive performance than others [60, 63].
Cerebral hypoperfusion can result in neural deterioration, and subsequently impaired cogni-
tion; however it is also possible that brain atrophy causes hypoperfusion due to decreased
demand for oxygen and nutrients. The cross-sectional design of the study limits the extent to
which causality can be deduced, further study is required to address whether blood flow
changes are a cause or a consequence of brain shrinkage with age.
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Conclusion
In summary, the current research showed that healthy aging is linked to inferior memory and
attention, reduced total cerebral blood flow and a trend towards increased oxygen extraction,
whilst blood flow and oxygen metabolism in the grey matter is maintained. These results indi-
cate that there is some imbalance between the demand and the supply for oxygen and nutrients
in the brain, even in successful aging. CBF was shown to contribute to attention task perfor-
mance, though this relationship was in an unexpected direction with higher flow associated
with poorer performance. The results of this study suggest that the association between CBF
and cognition is age-dependent and task-specific. Overall deterioration in the aging brain
results in losses of synaptic and vascular density and viability, and these diminishing functions
may be responsible for the progressive slowing of cognitive speed, particularly in the realm of
attention. Understanding how vascular and metabolic factors impact on cognition in normal,
healthy adults is essential to develop efficient therapies to prevent and treat cognitive losses in
older age. Future research employing regional brain area analyses and incorporating larger
sample sizes is necessary to continue to investigate these relationships, in addition to the inclu-
sion of cognitively impaired elderly to assess whether there are differential associations
between CMRO2, Yv, CBF and cognitive performance between impaired and healthy aging.
Materials and methods
Participant characteristics
Vascular, metabolic and cognitive function was assessed in 60 healthy (active, asymptomatic,
independently-living) adults. Two separate age groups were formed, the younger group <50
years (n = 31, ages 21–44, M 29.97 years, SD 6.17, 13 females) and the older aged>50 (n = 29
ages 55–75, M 65.00 years, SD 5.56, 16 females). Exclusion criteria included contraindications
for MRI, left handedness, existing or previous cardiovascular or psychiatric disorders, blood
pressure above 140/90mmHg, diabetes, pregnancy, use of medication for cardiovascular, neu-
rologic or psychiatric disorders, and any other chronic illness. A telephone-based assessment
(the Modified Telephone Interview for Cognitive Status- TICS-m [71]) was used to screen for
mild cognitive impairment and dementia for participants aged over 45 years. Participants scor-
ing 23 or below were omitted from the final analysis (n = 3). After receiving an explanation of
the study procedure, participants provided written informed consent. This study was granted
ethical approval by: Alfred Hospital Ethics Committee (338/13) and Swinburne University
Human Research Ethics Committee (2013/316). Participant characteristic information is pre-
sented in Table 1.
Experimental design and procedure
Data was acquired in one testing session, approximately 3 hours length. Each participant had
their blood pressure taken by a registered nurse, and then underwent a magnetic resonance
imaging (MRI) scan. A 30-minute computerized cognitive assessment followed.
MRI data acquisition. Data was collected using a 3T Siemens Tim Trio MRI system (Sie-
mens, Erlangen, Germany) fitted with a 32-channel head coil at Swinburne University, Haw-
thorn, Australia. Participants were requested to minimize head movements, and foam padding
was inserted around the head to aid this.
Total and grey matter cerebral blood flow. Phase contrast MRI uses the phase of
acquired images to determine the velocity of moving spins to obtain quantitative whole-brain
blood flow measurements. Based on the maximum intensity projection reconstruction of the
TOF angiogram, each of the four feeding arteries of the brain (left and right internal carotid
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arteries and left and right vertebral arteries) were scanned separately [72]. Scans were oriented
perpendicular to the arteries, and positioned with the center of the FOV placed at the center of
each target vessel Imaging parameters were: single slice, peripherally gated, TR 41.3ms, TE
4ms, FA 25˚, FOV 160 x 160 x 5mm3, voxel size 0.5 x 0.5 x 5mm3, maximum velocity encoding
100cm/s. The flow (velocity x area) through the four arteries was summed together and multi-
plied by 60s/min to give the total CBF (tCBF) in ml/min. Mean grey matter CBF (gmCBF) was
calculated by dividing the total CBF by grey matter volume relative to white matter volume.
White matter flow was assumed to be 40% of grey matter flow [25]. This ratio and the grey and
white matter volumes obtained from the segmentation procedure were used to calculate tis-
sue-specific flow and metabolism rates. Equations for gmCBF are supplied in Supplementary
Material.
Measurement of gmCMRO2. Grey matter CMRO2 was estimated due to differing rates of
volume loss and oxygen metabolism between tissue types with age. This study employed a
technique developed by Xu et al. [73], improved upon by Liu et al. [72], using independent
MRI estimates of venous blood oxygenation (Yv) and cerebral blood flow. A 30-second base-
line of arterial oxygen saturation was acquired with a pulse oximeter and averaged for each
participant to give the value of Ya. Total CBF (tCBF) was measured using phase-contrast MRI
and Yv was estimated using T2- relaxation-under-spin-tagging (TRUST) [74]. Grey matter
CBF (gmCBF) was calculated from tCBF values as shown in Supplementary Material. Fick’s
principle of arteriovenous difference [75] was used to quantify the rate of cerebral oxygen
metabolism as per previous research [33, 76–79]. The equation was adapted for grey matter:
gmCMRO2 ¼ gmCBF:ðYa   YvÞ:Ca ½1
Where gmCBF is the cerebral blood flow in ml/100g grey matter/min, Ya and Yv are the per-
centage of oxygen saturation of the arterial and the venous blood respectively, and Ca is the
blood’s oxygen carrying capacity, generally established in the literature as 833.7 μmol of O2/
100ml of blood for a hematocrit level of 0.44 [80]. Previous research [21] reports age- and gen-
der-dependence in hemoglobin concentration. To overcome this confound, Ca was set
at856 μmol of O2/ 100ml blood for young males and 815 μmol of O2/ 100ml of blood for
young females, for hematocrit levels of 0.42 and 0.40 respectively, as per previous research
[80], and was adjusted for the decline rate of 0.0079 μmol of O2/ml/year [21]. This value had
little effect on the calculation as a whole; experimental substitution with a single average value
of 833.7 μmol of O2/ 100ml of blood for all participants did not affect the outcome of statistical
analyses.
All data processing was performed off-line with MATLAB 2014b (The MathWorks Inc.,
Natick, MA, 2014) using SPM12 (SPM12, University College of London, UK) or software
developed in house. MATLAB scripts were used to segment the T1-weighted images of the
brain into grey and white matter volumes using SPM12.
A high-resolution T1-weighted image was acquired using a 3D magnetization-prepared
rapid gradient-echo (MPRAGE) image (axial, TR 2300ms, TE 2.52ms, voxel size 1 x 1 x 1mm3,
FOV 256mm, 176 slices) to provide an estimation of the intracranial, grey, and white volumes
for calculation of blood flow per unit mass of grey matter tissue. This accounts for variance in
brain size and atrophy across participants.
A whole-brain 3D time-of-flight (TOF) angiogram enabled visualization of the four feeding
arteries of the brain for phase-contrast MRI slice positioning (Fig 1). Imaging parameters were
TR 20ms, TE 3.59ms, flip angle 18˚, FOV 200 x 180 x 1mm3, voxel size 0.5 x 0.5 x 1mm3, 149
slices.
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Global venous oxygenation. TRUST quantitatively estimates the oxygenation of the
venous blood by measurement of pure blood T2 in the superior sagittal sinus (SSS). Imaging
parameters: single-shot echo-planar imaging (EPI), axial plane, TR 4000ms, TI 1400ms, four
effective TEs 0, 40, 80, 160ms; tagging thickness 50mm, gap 25mm, voxel size 1.4 x1.4 x 5mm3,
1 average, scan duration 2.20 min. The slice was parallel to the anterior- commissure poste-
rior-commissure (AC-PC) line with a distance of approximately 1cm above the confluence of
sinuses. Slice positioning was based on a middle sagittal survey image (Fig 2A). The control
and tagged images were subtracted pairwise to yield the venous blood signal, which was fitted
a mono-exponential function to obtain the T2. The T2 was then in turn converted to Yv via a
calibration plot as described previously [74, 81, 82].
Computerized cognitive assessment. Cognitive function was measured using the Swin-
burne University Computerized Cognitive Assessment Battery (SUCCAB) [83]. This validated
computerized test battery of 8 tasks is designed to capture the range of cognitive functions that
decline with age. Tests were administered in the following order: simple reaction time, two-
choice reaction time, immediate recognition memory (testing immediate memory of abstract
images), congruent and incongruent color-word Stroop tasks, spatial working memory (test-
ing working memory of spatial locations), contextual memory (testing recall memory of
objects in spatial locations), and delayed recognition memory (testing the delayed recall of
images from the immediate recognition memory component). Details of the tasks have been
described previously [83]. Participants completed the SUCCAB once with duration of approxi-
mately 30 minutes. Participants responded to each task using a button box [83]. The researcher
read the instructions aloud to ensure consistent explanation of all tasks. Each task was pre-
ceded by a brief practice trial. Memory and attention composite scores were calculated from
the SUCCAB. Response times for immediate and delayed recognition, spatial working and
contextual memory tasks were averaged to give the memory composite score. Simple and
choice reaction time, and the two Stroop task response times were averaged to give the atten-
tion composite score. The variables are weighted such that greater values indicate slower pro-
cessing times. The method of composition has been described previously [84].
Modified Telephone Interview for Cognitive Status (TICS-m). The TICS-m is a reliable
and validated brief 13-item test of cognitive functioning that is administered over the tele-
phone [71]. The items covered related to questions of orientation, repetition, naming and cal-
culations, with scores ranging from 0 to 35. The modified version of the TICS also includes
Fig 1. Location of phase contrast scans for the left and right ICA and VA.
https://doi.org/10.1371/journal.pone.0197055.g001
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immediate and delayed recall. Participants who scored 23 or below were omitted from the
final analysis (n = 3).
MRI data analysis. An in-house Matlab script was used for quantification of CBF, which
involved a region-of–interest (ROI) mask being manually drawn onto each target artery based
on the magnitude image of each PC MRI scan. The phase signals (i.e. velocity values) within
the masks were summed and combined with the cross-sectional area of each artery to calculate
blood flow in ml/min for each artery. Blood flow values of each artery along with the diameter
to convert to blood flow (ml/min). Velocities of the four arteries were added together to give
the total CBF. Brain volume differences were accounted for by normalizing total CBF in ml/
min to total grey matter (Vgm) and white matter (Vwm) in grams to give estimates of CBF in
the grey and white matter separately. Grey and white matter volumes were estimated from the
T1 structural MPRAGE scan using voxel-based morphometry (VBM8) segmentation with
SPM12 software (SPM12, University College of London, UK). CMRO2 per unit mass of grey
matter was calculated according to Eq 1 above. Eq 1 was used to obtain unit-mass grey matter
CMRO2 μmol of O2 per 100g of grey matter per minute as per previous literature [32].
Fig 2. Quantification of the venous oxygenation using T2- relaxation-under- spin- tagging (TRUST) MRI A) The
location of the labeling slab region (orange block) of the TRUST scan upstream from the imaging slice (red line). T2
blood signal was acquired from the superior sagittal sinus (SSS) B) Raw axial images of the control and labelled scans,
SSS region is shown in the orange box. The label inverts the venous blood signal so it appears dark in the image.
https://doi.org/10.1371/journal.pone.0197055.g002
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Statistical analyses
IBM SPSS statistics v.23 (Chicago, IL, USA) was used to conduct analysis. Means and standard
deviations for patient characteristics, baseline vascular and metabolic (tCBF, gmCBF, Yv and
gmCMRO2) structural markers (ICV, Vgm and Vwm), and cognitive composite scores are
shown in Table 1 for the whole sample and separately by age group. Differences between age
groups were assessed using one-way independent samples analyses of variances (ANOVAs).
Univariate general linear models (GLMs) were used to assess the main effects of age and gen-
der on physiologic variables for each age group separately.
Separate univariate GLMs were performed for each age group to assess the main effects of
vascular and metabolic factors to the cognition measures separately. Age, years of education
and the vascular, ratio or metabolic factors were entered as fixed factors, and age was entered
as a covariate. P values of 0.05 or less were considered statistically significant in all analyses;
however a correction for multiple comparisons (Bonferroni’s correction) was applied to adjust
for the inclusion of two physiological measures in the hypotheses. Significance level was
adjusted for two comparisons in the univariate linear regression analyses (p 0.025). P values
between 0.06 and 0.05 were considered to be marginally significant prior to correction, and
reported as such.
Calculation of grey matter cerebral blood flow (gmCBF). Calculation of CBF in the grey
and white matter on the assumption that white matter flow is approximately 40% that of grey
matter as per previous literature [25]. The following equations were used to estimate gmCBF
from tCBF values:
tCBFv ¼ tCBF=ðVgmþ VwmÞ:p ½2
tCBFv ¼ gmCBFvþ wmCBFv ½3
wmCBFv ¼ 0:4:gmCBFv ½4
tCBFv ¼ gmCBFv þ 0:4:gmCBFv ¼ 1:4:gmCBFv ½5
gmCBFv ¼ tCBFv=1:4 ¼ tCBF=ð1:4:ðVgmþ VwmÞ:pÞ ½6
Where Vgm and Vwm are the volumes of grey and white matter respectively in ml. ρ is the
mass density of tissue used as the scaling factor to convert tissue volumes to mass, assumed as
1.06g/ml [85]. tCBFv is the volume-corrected total CBF, normalized to the volumes of grey
and white matter, in ml/100g brain tissue/ min. gmCBFv and wmCBFv are the volume cor-
rected blood flows for grey and white matter respectively. A 30-second baseline of arterial oxy-
gen saturation was acquired with a pulse oximeter and averaged for each participant to give
the value of Ya. tCBF was measured using phase-contrast MRI and Yv was estimated using T2-
relaxation-under-spin-tagging (TRUST) [74].
Supporting information
S1 Table. Table showing the results of univariate GLM on age, gender, education and tCBF
contributions to memory score for younger and older adults. R2 values for younger adults
was .17, and older adults was .10.
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S2 Table. Table showing the results of univariate GLM on age, gender, education and
gmCBF contributions to memory score for younger and older adults. R2 values for younger
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